It’s hard to believe, but a year ago the Florida governor

New Post Public Reply Private Reply Replies (0) Message Board
Bhawks
127
It’s hard to believe, but a year ago the Florida governor was the nominal GOP frontrunner. But when he started actually running for president—it all went south.

Matt Lewis Senior Columnist
Published Jan. 19, 2024 8:01PM EST
https://www.thedailybeast.com/7-reasons-ron-d...l?ref=home



Those who don’t learn from history are doomed to repeat it. Had Ron DeSantis learned from the mistakes made by Donald Trump’s 2016 rivals, he would have run a better campaign (or skipped it altogether).

Instead, it seems likely that DeSantis’ presidential bid will end with his reputation being in much worse shape than when the campaign began. But was this always preordained? Was Trump’s (likely) victory a foregone conclusion? I don’t think so.

However, DeSantis’ campaign, such as it was, went off the tracks even before his official campaign announcement last summer. From where I stand, there are seven main reasons this happened.

1. Florida taught him the wrong lessons.

DeSantis should have read a business book called, What Got You Here Won’t Get You There. People tend to think what made them successful at one level will make them successful at the next. Often, it doesn’t. In a sense, DeSantis was cursed by his success in Florida.

Rather than forcing DeSantis to improve his weaknesses, his success at the state level allowed him to skate by and avoid doing things he wasn’t good at.

Take, for example, the way he snubbed the “national regime media” (something he now regrets). During his time as Florida’s governor, DeSantis either avoided the mainstream media (and catered to conservative “influencers”), or he bullied them (and used them as press conference props). This worked wonderfully in Florida, but it wasn’t scalable.

Eventually, DeSantis was forced to do interviews with mainstream shows. Honestly, though, he wasn’t great at them, partly because he had little experience learning how to answer questions that he perceived as unfriendly. Protectionism, it turns out, doesn’t work.

2. DeSantis waited too long to get in the race.

In politics, “Speed kills.” You define your opponent before he defines you. You strike while the iron is hot. These clichés became clichés for a reason.

Unfortunately, DeSantis could not call a snap election and try to beat Trump right after the 2022 midterms when his popularity peaked, but he could have aggressively begun redefining Trump. Instead, DeSantis focused on piling up a list of accomplishments during Florida’s legislative session, under the premise that the voters might care about his ability to put points on the board. They didn’t.

On paper, it made sense that GOP primary voters might want a more-competent Trump—someone able to take ideas they already liked and put them into law. When it comes to GOP primary voters, at least, he misread the audience.

3. Like Ted Cruz in 2016, he thought ideological purity mattered.

Today’s GOP primary voters are not persuaded based on conservative orthodoxy. So by tacking to Trump’s right on abortion, for example, DeSantis not only failed to catch fire with primary voters, but he arguably hurt his electability argument, as it pertains to who could defeat Joe Biden. These miscalculations were bound to happen with so many Cruz veterans in the DeSantis orbit (and running DeSantis’ SuperPac).

4. He assumed that Trump would fade and he could inherit his voters.

How many times have Republican candidates rationalized ignoring Trump, based on the assumption that Trump would drop out of the race—or that voters would simply move on from him?

Had DeSantis jumped in the race early and aggressively defined (i.e., attacked) Trump and set the 2024 campaign narrative (i.e., “what this election’s about”) to focus on electability, he might have preemptively framed Trump’s first indictment as a massive blow. For example, DeSantis might have spent months warning that an indictment was coming, and that said indictment would doom Trump’s chances against Biden in November. Instead, he did something even worse.

5. He provided cover for Trump.

It’s not just that DeSantis failed to effectively attack Trump, it’s that he defended Trump from what might have been serious developments. By helping Trump suggest that the indictments were politically motivated and later saying he would pardon the former president, DeSantis contributed to a permission structure whereby Republican voters had every reason to remain loyal to Trump, rather than moving on from him.

6. He didn’t shore-up non-Trump Republican voters first.

Rather than locking down a coalition of gettable non-Trump Republicans and then attempting to woo soft Trump voters who were ready to move on, DeSantis first attempted to court hard-core Trumpy voters. It’s hard to imagine how or why he thought this would work. On top of that, he took stances (such as calling Russia’s Ukraine invasion a “territorial dispute”) that repelled formerly gettable Reagan Republicans (providing a rationale for Nikki Haley’s candidacy).

7. He bought into the ‘very online’ hype.

Once it became apparent that rank-in-file Trump voters weren’t going for Trump Lite, DeSantis still refused to focus on consolidating the rest of the GOP electorate.

Instead of worrying about the kind of normie voter who might caucus in Des Moines, he focused on the young and highly-educated, very online voters (a priority that was reflected in his staff hiring decisions). DeSantis had swerved toward Edgelord territory. This led to weird decisions, such as hosting his official campaign announcement on Twitter Spaces, a move that turned disastrous when the feed crashed for the first 20 minutes (and that was only one of many technical calamities).

Building on his Florida experience (see listicle number 1), he also spent much of his early presidential campaign focused on culture war issues like attacking “wokism,” pushing vaccine skepticism and banning local COVID-19 mask requirements, or going after Disney and calling people “groomers.”

In some ways, DeSantis’ failure to catch fire was predictable. I predicted it in May—months before he officially launched his campaign. But I don’t believe in predestination in politics. The world is dynamic. If DeSantis had started off in Jan. 2023 with the right strategy and message, things might have turned out different.

While one could argue that DeSantis’ awkwardness or introversion doomed him—or that the indictments made Trump unbeatable by causing Republicans to circle the wagons around him—I believe that a radically different type of campaign strategy might have worked.

At the end of the day, it seems likely that DeSantis’ ego blinded him to some of the realities, stopping him from learning some of the lessons of 2016, and preventing him from doing the things that might have made him the GOP nominee in 2024.

In this regard, Ron DeSantis is a cautionary tale.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 313

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 193

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 128

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 130

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 224

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 332

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 134

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 541

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 161

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading

Top 5 Most Recently Viewed Articles

Phreesia Announces Q3 Fiscal Year 2025 Financial Results

Updated Category News Views 71

Phreesia to Release Fiscal Q3 2025 Results Soon Phreesia, Inc. (NYSE: PHR) has great news for its stakeholders! The company revealed plans to announce its financial results for the third quarter of fiscal year 2025 right after market closing on a Monday in December. During this quarter, the firm experienced substantial growth and is eager to share the details with the...

Continue Reading
Innovative Water Bowl Design Enhances Pet Hydration Experience

Updated Category News Views 374

Revolutionary Pet Water Bowl Crafted for Optimal Hydration Every pet owner knows the importance of keeping their furry friends hydrated, especially during hot days. A new invention promises to enhance the experience for pets and their owners alike. This innovative water bowl, known as the THERMA DRINK, is designed with features that cater directly to pet needs. The idea...

Continue Reading
HPH's Leadership Changes Signify Strategic Direction Ahead

Updated Category News Views 177

Leadership Transitions at HPH Highest Performances Holdings Inc. (NASDAQ: HPH) has recently seen a notable change in its Board of Directors. The company announced that Mr. Peh Chin Hua's tenure as Director has come to an end, effective immediately. This decision is part of a broader strategy aimed at strengthening the Board's overall composition and capabilities. Current...

Continue Reading
Apranga Group Reports Growth in Retail Turnover for 2025

Updated Category News Views 132

Apranga Group Retail Performance Overview for 2025 Apranga Group, a major player in the retail sector, has announced its impressive financial performance for the first six months of 2025, demonstrating notable growth compared to the prior year. The company's retail turnover reached a commendable EUR 166.1 million, reflecting a 2.8% increase from the same period in 2024....

Continue Reading
IMUNON Unveils Promising New Vaccine Data for COVID-19

Updated Category News Views 154

New Vaccine Insights from IMUNON's Phase 1 Clinical Trial The innovative PlaCCine technology platform developed by IMUNON, Inc. (NASDAQ: IMNN) promises remarkable durability and advantages over traditional mRNA vaccines, particularly in the struggle against COVID-19. Robust Results from IMNN-101 Vaccine Trials In an encouraging announcement, IMUNON shared pivotal data...

Continue Reading